🔎Important perspectives on access to cardiovascular innovation in France – Cardiawave

March 3, 2026

A recent Le Monde op-ed signed by leading experts in interventional cardiology highlights delays in accessing cutting-edge medical devices in France — delays that may represent a real loss of opportunity for patients.

 At Cardiawave, we believe that patients should benefit rapidly and safely from validated, life‑changing technologies. ⚡❤️‍🩹 Ensuring timely access to innovation is essential to improving cardiovascular outcomes and supporting medical teams in their mission. 🌍

 We deeply value the commitment of many cardiovascular organizations working to advance patient care and improve access to innovation in France.

 🔗 Op-ed (Le Monde — subscription required):
“Pour une refonte urgente des conditions d’accès à l’innovation en France”
https://www.lemonde.fr/sciences/article/2026/02/24/pour-une-refonte-urgente-des-conditions-d-acces-a-l-innovation-en-france_6668075_1650684.html

 @Société Française de Cardiologie @Fondation Cœur & Recherche
@Alliance du Cœur #MedTech #StructuralHeart #Innovation #AorticStenosis #CardiovascularInnovation #Valvosoft #medtech #focusedultrasound #innovation #NIUT #TAVI #TAVR #AorticValve #lifetimemanagementofas #valves #CEMarking